Developing microphysiological systems for use as regulatory tools – challenges and opportunities

Melvin E. Andersen; Kellyn Betts; Yvonne Dragan; Suzanne Fitzpatrick; Jesse L. Goodman; Thomas Hartung; Jonathan Himmelfarb; Donald E. Ingber; Abigail Jacobs; Robert Kavlock; Kyle Kolaja; James L. Stevens; Dan Tagle; D. Lansing Taylor; Douglas Throckmorton

doi:10.14573/altex.1405151

pdf sup

Published: Aug 1, 2014

DOI: https://doi.org/10.14573/altex.1405151

Melvin E. Andersen, Kellyn Betts , Yvonne Dragan, Suzanne Fitzpatrick, Jesse L. Goodman, Thomas Hartung, Jonathan Himmelfarb, Donald E. Ingber, Abigail Jacobs, Robert Kavlock, Kyle Kolaja, James L. Stevens, Dan Tagle, D. Lansing Taylor, Douglas Throckmorton
[show affiliations]

Melvin E. Andersen

Hamner Institutes for Health Sciences, Research triangle Park, NC, USA

Kellyn Betts

Freelance Science and Technology Writer, Takoma Park, MD, USA

Yvonne Dragan

AstraZeneca, Waltham, MA, USA

Suzanne Fitzpatrick

Center for Food Safety and Applied Nutrition, Food and Drug Administration, Silver Spring, MD, USA

Jesse L. Goodman

Food and Drug Administration, Silver Spring, MD, USA

Thomas Hartung

Johns Hopkins University Center for Alternatives to Animal testing, Baltimore, MD, USA

Jonathan Himmelfarb

Kidney Research Institute, University of Washington, Seattle, WA, USA

Donald E. Ingber

Wyss Institute for Biologically Inspired engineering, Harvard University, Cambridge, MA, USA

Abigail Jacobs

Center for Drug evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA

Robert Kavlock

U.S. Environmental Protection Agency, Research Triangle Park, NC, USA

Kyle Kolaja

Cellular Dynamics International, Inc., Madison, WI, USA

James L. Stevens

Lilly Research Laboratories, Greenfield, IN, USA

Dan Tagle

National Center for Advancing translational Sciences, National Institutes of Health, Bethesda, MD, USA

D. Lansing Taylor

Drug Discovery Institute, University of Pittsburgh, Pittsburgh, PA, USA

Douglas Throckmorton

Center for Drug evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA

[hide affiliations]

How to Cite

Andersen, M. E. (2014) “Developing microphysiological systems for use as regulatory tools – challenges and opportunities”, ALTEX - Alternatives to animal experimentation, 31(3), pp. 364–367. doi: 10.14573/altex.1405151.

Issue

Vol. 31 No. 3 (2014)

Section

Meeting Reports

Articles are distributed under the terms of the Creative Commons Attribution 4.0 International license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium, provided the original work is appropriately cited (CC-BY). Copyright on any article in ALTEX is retained by the author(s).

Most read articles by the same author(s)

Lena Smirnova, Nicole Kleinstreuer, Raffaella Corvi, Andre Levchenko, Suzanne C. Fitzpatrick, Thomas Hartung, 3S - Systematic, systemic, and systems biology and toxicology , ALTEX - Alternatives to animal experimentation: Vol. 35 No. 2 (2018)
Cristian Pellizzer, Susanne Bremer, Thomas Hartung, Developmental toxicity testing from animal towards embryonic stem cells , ALTEX - Alternatives to animal experimentation: Vol. 22 No. 2 (2005)
Christian Koppelstaetter, Paul Jennings, Michael P. Ryan, Jean-Paul Morin, Thomas Hartung, Walter Pfaller, Assessment of a new cell culture perfusion apparatus for in vitro chronic toxicity testing. Part 1: Technical description , ALTEX - Alternatives to animal experimentation: Vol. 21 No. 2 (2004)
Paul Jennings, Christian Koppelstaetter, Walter Pfaller, Jean-Paul Morin, Thomas Hartung, Michael P. Ryan, Assessment of a new cell culture perfusion apparatus for in vitro chronic toxicity testing. Part 2: Toxicological evaluation , ALTEX - Alternatives to animal experimentation: Vol. 21 No. 2 (2004)
David Pamies, Anna Bal-Price, Christophe Chesné, Sandra Coecke, Andras Dinnyes, Chantra Eskes, Regina Grillari, Gerhard Gstraunthaler, Thomas Hartung, Paul Jennings, Marcel Leist, Ulrich Martin, Robert Passier, Jens C. Schwamborn, Glyn N. Stacey, Heidrun Ellinger-Ziegelbauer, Mardas Daneshian, Advanced Good Cell Culture Practice for human primary, stem cell-derived and organoid models as well as microphysiological systems , ALTEX - Alternatives to animal experimentation: Vol. 35 No. 3 (2018)
Megan Chesnut, Takashi Yamada, Timothy Adams, Derek Knight, Nicole Kleinstreuer, George Kass, Thomas Luechtefeld, Thomas Hartung, Alexandra Maertens, Regulatory acceptance of read-across , ALTEX - Alternatives to animal experimentation: Vol. 35 No. 3 (2018)
Stefanie Schindler, Adrian Bristow, Tammy Cartmell, Thomas Hartung, Stefan Fennrich, Comparison of the reactivity of human and rabbit blood towards pyrogenic stimuli , ALTEX - Alternatives to animal experimentation: Vol. 20 No. 2 (2003)
Lucy Meigs, Lena Smirnova, Costanza Rovida, Marcel Leist, Thomas Hartung, Animal testing and its alternatives – the most important omics is economics , ALTEX - Alternatives to animal experimentation: Vol. 35 No. 3 (2018)
Mario Beilmann, Harrie Boonen, Andreas Czich, Gordon Dear, Philip Hewitt, Tomas Mow, Peter Newham, Teija Oinonen, Francois Pognan, Adrian Roth, Jean-Pierre Valentin, Freddy Van Goethem, Richard Weaver, Barbara Birk, Scott Boyer, Francesca Caloni, Alice Chen, Raffaella Corvi, Mark Cronin, Mardas Daneshian, Lorna Ewart, Rex Fitzgerald, Geraldine Hamilton, Thomas Hartung, Joshua Kangas, Nynke Kramer, Marcel Leist, Uwe Marx, Sebastian Polak, Costanza Rovida, Emanuela Testai, Bob van der Water, Paul Vulto, Thomas Steger-Hartmann, Optimizing drug discovery by investigative toxicology: Current and future trends , ALTEX - Alternatives to animal experimentation: Vol. 36 No. 2 (2019)
Thomas Hartung, Rob de Vries, Sebastian Hoffmann, Helena T. Hogberg, Lena Smirnova, Katya Tsaioun, Paul Whaley, Marcel Leist, Toward Good In Vitro Reporting Standards , ALTEX - Alternatives to animal experimentation: Vol. 36 No. 1 (2019)

<< < 5 6 7 8 9 10 11 12 13 14 > >>

Article Sidebar

Main Article Content

Article Details

Most read articles by the same author(s)